Anthony Magnano, MD
Clinical Cardiac Electrophysiology · Jacksonville, FLNPI 1164494563
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.7%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Johnson & Johnson at 40.8% of the total. Reporting peaked in 2019 at $12,280 and has fallen 94.8% since, to $639 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in FL, where the typical reported total is $25,729.
Across 151 payments — averaging $153.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$9K
- Medtronic$7K
- Boston Scientific$3K
- Biosense Webster, Inc.$1K
- Altathera Pharmaceuticals LLC$500
- Abbott$472
- plus $2K from 20 others
Across 20 payments — averaging $3205.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Volta Medical Inc$29K
- Medtronic$25K
- Abbott$10K
What the payments were for
- Consulting fees$5,60024%
- Speaking & faculty fees$9,70042%
- Travel & lodging$1,5647%
- Food & beverage$6,37827%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 20 | $9,491 |
| Medtronic(2 entities) | 24 | $6,939 |
| Boston Scientific | 36 | $2,785 |
| Biosense Webster, Inc. | 21 | $1,308 |
| Altathera Pharmaceuticals LLC | 1 | $500 |
| Abbott | 6 | $472 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $239 |
| Novartis | 6 | $220 |
| Haemonetics Corporation | 1 | $150 |
| Cardiva Medical, Inc. | 2 | $143 |
| Atricure, Inc. | 1 | $141 |
| Abiomed | 1 | $132 |
| Edwards Lifesciences | 1 | $123 |
| Irhythm Technologies, Inc. | 1 | $109 |
| Amgen | 5 | $84 |
| Elutia, Inc. | 3 | $75 |
| Sanofi-aventis U.S. LLC | 4 | $65 |
| E.r. Squibb & Sons, L.L.C. | 4 | $59 |
| Shockwave Medical, Inc | 1 | $56 |
| Astellas Pharma US Inc | 2 | $41 |
| Acutus Medical, Inc. | 1 | $34 |
| AstraZeneca | 1 | $17 |
| Braemar Manufacturing, LLC | 1 | $17 |
| Convatec Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$9,312
- Micra$892
- Sotalol Hydrochloride$500
- Carto 3$467
- MitraClip System$305
- WATCHMAN FLX$249
- Watchman$157
- WATCHMAN Access System$150
- TEG6s HEMOSTASIS SYSTEM$150
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, MODELS$141
- Impella$132
- LEQVIO$125
- CARDIVA VASCADE MVP XL VVCS 10-12F$125
- QDOT MICRO Catheter$124
- Edwards SAPIEN 3 Transcatheter Heart Valve$123
- GENERAL TACHY$118
- ARCTIC FRONT ADVANCE$117
- ZIO Patch$109
How this compares
$23,242 in reported general payments places this provider in the 45th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 948 | $1,051,354 |
| XareltoRivaroxaban | 196 | $220,168 |
| MultaqDronedarone Hcl | 121 | $168,032 |
| EntrestoSacubitril/Valsartan | 65 | $91,096 |
| Flecainide Acetate | 201 | $11,370 |
| Metoprolol Succinate | 464 | $6,085 |
| Amiodarone Hcl | 352 | $5,704 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 18 | $3,532 |
| Dofetilide | 32 | $3,526 |
| SotalolSotalol Hcl | 150 | $3,468 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 107 | $3,312 |
| Ranolazine ErRanolazine | 20 | $2,308 |
| Nebivolol Hcl | 20 | $2,271 |
| Carvedilol | 218 | $2,061 |
| Metoprolol Tartrate | 220 | $1,406 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $12 | $1,051,354948 claims |
| Johnson & JohnsonXarelto | $9,491 | $220,168196 claims |
| Sanofi-aventis U.S. LLCMultaq | $65 | $168,032121 claims |
| NovartisEntresto | $220 | $91,09665 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Jacksonville
- Saumil OzaJacksonville$462K
- Matthew McKillopJacksonville$119K
- Aaditya VoraJacksonville$62K
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
- Brian BetenskySarasota$412K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.